Synthesis and antidyslipidemic activity of chalcone fibrates
摘要:
A series of chalcone based PPAR-alpha agonists were synthesized and evaluated for their antidyslipidemic activity in high fructose high fat fed dyslipidemic Syrian golden hamsters. Most of the compounds exhibited antidyslipidemic activity. The compounds 4c and 4f have been identified as most potent antidyslipidemics. A definite structure-activity relationship was observed while varying the nature as well as the position of the substituent. (C) 2011 Elsevier Ltd. All rights reserved.
Synthesis and antidyslipidemic activity of chalcone fibrates
摘要:
A series of chalcone based PPAR-alpha agonists were synthesized and evaluated for their antidyslipidemic activity in high fructose high fat fed dyslipidemic Syrian golden hamsters. Most of the compounds exhibited antidyslipidemic activity. The compounds 4c and 4f have been identified as most potent antidyslipidemics. A definite structure-activity relationship was observed while varying the nature as well as the position of the substituent. (C) 2011 Elsevier Ltd. All rights reserved.
Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents
申请人:Pratap Ram
公开号:US20060142303A1
公开(公告)日:2006-06-29
The present invention provides novel substituted chalcone derivatives which exhibit anti-hyperglycemic and anti-dyslipedemic activity. The invention also provides a method for treating type II diabetes and associated hyperlipidemic conditions in a mammal by administering the compounds of the present invention and compositions containing these derivatives.
Synthesis and antidyslipidemic activity of chalcone fibrates
作者:Poonam Shukla、Swayam P. Srivastava、Rohit Srivastava、Arun K. Rawat、Arvind K. Srivastava、Ram Pratap
DOI:10.1016/j.bmcl.2011.03.057
日期:2011.6
A series of chalcone based PPAR-alpha agonists were synthesized and evaluated for their antidyslipidemic activity in high fructose high fat fed dyslipidemic Syrian golden hamsters. Most of the compounds exhibited antidyslipidemic activity. The compounds 4c and 4f have been identified as most potent antidyslipidemics. A definite structure-activity relationship was observed while varying the nature as well as the position of the substituent. (C) 2011 Elsevier Ltd. All rights reserved.